Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Invitae Corp NVTAQ

Healthcare
Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. It offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. It applies... see more

Recent & Breaking News (GREY:NVTAQ)

Invitae Expands Detect Program to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients

PR Newswire September 9, 2019

Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes

PR Newswire September 6, 2019

Invitae Announces Proposed Offering of $200 Million of Convertible Senior Notes

PR Newswire September 4, 2019

Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients

GlobeNewswire August 20, 2019

Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume

PR Newswire August 6, 2019

Invitae Launches Detect Programs to Make it Easier for Patients to Get Genetic Testing for Prostate Cancer, Muscular Dystrophy and Heart Conditions

PR Newswire July 24, 2019

Invitae to announce second quarter 2019 financial results on August 6, 2019

PR Newswire July 23, 2019

Invitae to Acquire Jungla to Advance Genetic Variant Interpretation, Adds Supplemental RNA Analysis to Deliver Deeper, More Informative Results to Patients

PR Newswire July 11, 2019

Capital Market Laboratories (CMLviz) Interviews Invitae's CEO -Invitae's Non-Invasive Prenatal Screening Tests Can be a 50% Gross Margin Business

GlobeNewswire June 27, 2019

Invitae Reports Inducement Grants Under NYSE Rule 303A.08 to Former Employees of Singular Bio, Inc. in Connection with Closing of Acquisition

PR Newswire June 20, 2019

Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancy

PR Newswire June 17, 2019

X4 Pharmaceuticals and Invitae Announce Partnership to Provide No-Cost Genetic Testing to Patients Suspected of Primary Immunodeficiency Disease

Business Wire June 12, 2019

Invitae Announces ID YOUR IRD Program to Expand Access to Genetic Testing for Inherited Retinal Disorders

PR Newswire June 12, 2019

Invitae introduces new service to make it easier for consumers to receive the medical genetic testing that experts trust

PR Newswire June 3, 2019

Research from Invitae Demonstrates the Importance of Germline Multigene Panel Testing in Guiding Therapy for Expanding Groups of Cancer Patients

PR Newswire May 31, 2019

Horizon Therapeutics plc and Invitae Corporation Launch Urea Cycle Disorder Genetic Testing Program

Business Wire May 29, 2019

Invitae to Present at the 2019 William Blair Growth Stock Conference

PR Newswire May 22, 2019

Invitae to Present at the UBS Global Healthcare Conference

PR Newswire May 15, 2019

Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year

PR Newswire May 7, 2019

New Study From Invitae Highlights the Importance of Multigene Genetic Testing for Uterine Cancer Patients

PR Newswire May 3, 2019